IS7829A - Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun - Google Patents
Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkunInfo
- Publication number
- IS7829A IS7829A IS7829A IS7829A IS7829A IS 7829 A IS7829 A IS 7829A IS 7829 A IS7829 A IS 7829A IS 7829 A IS7829 A IS 7829A IS 7829 A IS7829 A IS 7829A
- Authority
- IS
- Iceland
- Prior art keywords
- new
- production
- diazabicycloalkane derivatives
- diazabicycloalkane
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201456 | 2002-09-30 | ||
DKPA200201738 | 2002-11-11 | ||
PCT/DK2003/000639 WO2004029053A1 (en) | 2002-09-30 | 2003-09-29 | Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7829A true IS7829A (is) | 2005-04-28 |
Family
ID=34828377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7829A IS7829A (is) | 2002-09-30 | 2005-04-28 | Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun |
Country Status (12)
Country | Link |
---|---|
JP (1) | JP4711391B2 (is) |
KR (1) | KR20050062575A (is) |
CN (1) | CN1326857C (is) |
BR (1) | BR0314183A (is) |
HK (1) | HK1081954A1 (is) |
IL (1) | IL166821A (is) |
IS (1) | IS7829A (is) |
MX (1) | MXPA05003344A (is) |
NO (1) | NO20052124L (is) |
PT (1) | PT1551835E (is) |
RU (1) | RU2323218C2 (is) |
SI (1) | SI1551835T1 (is) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3019B1 (ar) * | 2006-04-19 | 2016-09-05 | Janssen Pharmaceutica Nv | ثلاثي مستبدل 4،2،1-ثلاثي زولات |
DE602007006486D1 (de) * | 2006-05-30 | 2010-06-24 | Neurosearch As | Neuartige 1,4-diaza-bicycloä3.2.2ünonyl-oxadiazolyl-derivate und ihre medizinische verwendung |
US8492378B2 (en) | 2006-08-03 | 2013-07-23 | Takeda Pharmaceutical Company Limited | GSK-3β inhibitor |
EP2121688A1 (en) * | 2007-02-15 | 2009-11-25 | Argenta Discovery Ltd | Heterocyclic derivatives as m3 muscarinic receptors |
WO2013072705A1 (en) | 2011-11-18 | 2013-05-23 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
EA201800367A1 (ru) * | 2015-12-10 | 2019-02-28 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения болезни хантингтона |
CN108727293B (zh) * | 2016-09-18 | 2021-05-11 | 广西师范大学 | 1,2,8-氧代二氮杂环壬-9-酮衍生物及其合成方法 |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
KR20020027486A (ko) * | 1999-07-09 | 2002-04-13 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 신경영양성 피롤리딘 및 피페리딘, 및 그를 함유하는관련된 조성물 |
FR2804430B1 (fr) * | 2000-01-28 | 2002-03-22 | Sanofi Synthelabo | Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
FR2809732B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE |
FR2809731B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique |
US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
FR2832713B1 (fr) * | 2001-11-23 | 2004-02-13 | Sanofi Synthelabo | Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
-
2003
- 2003-09-29 JP JP2004538781A patent/JP4711391B2/ja not_active Expired - Fee Related
- 2003-09-29 SI SI200330715T patent/SI1551835T1/sl unknown
- 2003-09-29 RU RU2005105048/04A patent/RU2323218C2/ru not_active IP Right Cessation
- 2003-09-29 MX MXPA05003344A patent/MXPA05003344A/es active IP Right Grant
- 2003-09-29 PT PT03798094T patent/PT1551835E/pt unknown
- 2003-09-29 KR KR1020057005508A patent/KR20050062575A/ko not_active Application Discontinuation
- 2003-09-29 BR BR0314183-7A patent/BR0314183A/pt not_active Application Discontinuation
- 2003-09-29 CN CNB038232626A patent/CN1326857C/zh not_active Expired - Fee Related
-
2005
- 2005-02-10 IL IL166821A patent/IL166821A/en not_active IP Right Cessation
- 2005-04-28 IS IS7829A patent/IS7829A/is unknown
- 2005-04-29 NO NO20052124A patent/NO20052124L/no unknown
-
2006
- 2006-02-17 HK HK06102123A patent/HK1081954A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1551835E (pt) | 2007-03-30 |
RU2005105048A (ru) | 2005-11-20 |
NO20052124L (no) | 2005-06-29 |
NO20052124D0 (no) | 2005-04-29 |
IL166821A (en) | 2009-06-15 |
HK1081954A1 (en) | 2006-05-26 |
CN1684965A (zh) | 2005-10-19 |
RU2323218C2 (ru) | 2008-04-27 |
IL166821A0 (en) | 2006-01-15 |
MXPA05003344A (es) | 2005-11-23 |
CN1326857C (zh) | 2007-07-18 |
KR20050062575A (ko) | 2005-06-23 |
JP4711391B2 (ja) | 2011-06-29 |
JP2006503062A (ja) | 2006-01-26 |
SI1551835T1 (sl) | 2007-06-30 |
BR0314183A (pt) | 2005-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR18C1024I2 (fr) | Derives d'heterocyclocarboxamide | |
NO20055568D0 (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
IS5875A (is) | Ásetnar fenýlafleiður, framleiðsla þeirra og notkun | |
CY2014041I2 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
IS2040B (is) | Pýrasólínafleiður, framleiðsla þeirra og notkun sem lyfja | |
IS7881A (is) | CHK-, PDK- og AKT-hindrandi pýrimidín, framleiðsla þeirra og notkun sem lyfjaefni | |
IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
IS8698A (is) | Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja | |
IS7699A (is) | Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma | |
IS8383A (is) | Nýjar afleiður af 4a,5,9,10,11,12-hexahýdróbensófúró[3a,3,2][2]-bensasepín, aðferð við framleiðslu þeirra og notkun þeirra við framleiðslu á lyfjum | |
DK1513836T3 (da) | Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf | |
IS2174B (is) | Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun | |
DK1590321T3 (da) | Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf | |
IS7829A (is) | Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun | |
DK1556382T3 (da) | 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf | |
IS7980A (is) | Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun | |
ATE505459T1 (de) | Dibenzoäb,füazepin-derivate und ihre herstellung | |
IS2487B (is) | Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á | |
IS6403A (is) | Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun | |
IS7961A (is) | Díarýlmetýlídenpíperidínafleiður, lyfjablöndur þeirra og notkun þeirra | |
NO20044405L (no) | Neurotensinaktive 2,3-diaryl-pyrazolidin derivater | |
NO20044090L (no) | Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter | |
HK1061655A1 (en) | Caloporoside derivatives, methods for the production thereof and their use | |
IS8182A (is) | Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra |